Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial
Top Cited Papers
Open Access
- 9 January 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 30 (5), 540-548
- https://doi.org/10.1093/eurheartj/ehn571
Abstract
To evaluate the anti-anginal and anti-ischaemic efficacy of the selective If current inhibitor ivabradine in patients with chronic stable angina pectoris receiving beta-blocker therapy. In this double-blinded trial, 889 patients with stable angina receiving atenolol 50 mg/day were randomized to receive ivabradine 5 mg b.i.d. for 2 months, increased to 7.5 mg b.i.d. for a further 2 months, or placebo. Patients underwent treadmill exercise tests at the trough of drug activity using the standard Bruce protocol for randomization and at 2 and 4 months. Total exercise duration at 4 months increased by 24.3 ± 65.3 s in the ivabradine group, compared with 7.7 ± 63.8 s with placebo (P < 0.001). Ivabradine was superior to placebo for all exercise test criteria at 4 months (P < 0.001 for all) and 2 months (P-values between <0.001 and 0.018). Ivabradine in combination with atenolol was well tolerated. Only 1.1% of patients withdrew owing to sinus bradycardia in the ivabradine group. The combination of ivabradine 7.5 mg b.i.d. and atenolol at the commonly used dosage in clinical practice in patients with chronic stable angina pectoris produced additional efficacy with no untoward effect on safety or tolerability.Keywords
This publication has 26 references indexed in Scilit:
- Optimal Medical Therapy with or without PCI for Stable Coronary DiseaseThe New England Journal of Medicine, 2007
- Antianginal Efficacy and Safety of Ivabradine Compared with Amlodipine in Patients with Stable Effort Angina PectorisDrugs, 2007
- Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exerciseBritish Journal of Clinical Pharmacology, 2006
- Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS)Heart, 2006
- Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable anginaEuropean Heart Journal, 2005
- The initial management of stable angina in Europe, from the Euro Heart SurveyEuropean Heart Journal, 2005
- ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina)Journal of the American College of Cardiology, 2003
- Monotherapy with amlodipine or atenolol versus their combination in stable angina pectorisClinical Cardiology, 2000
- Amlodipine Versus Diltiazem as Additional Antianginal Treatment to AtenololThe American Journal of Cardiology, 1998
- Comparison of ischemic and physiologic responses during exercise tests in men using the standard and modified bruce protocolsThe American Journal of Cardiology, 1992